The Clorox Company (CLX)
Clorox: Undervalued Near Dividend King, And A Possible Even Better Strategy
Clorox (CLX) is rated a 'Buy' at $87.1, with a 37% undervaluation and 44.7% potential total return, supported by a robust dividend yield and conservative growth outlook. Short-term headwinds—ERP transition, supply chain costs, and high oil prices—are expected to ease, while the GOJO acquisition and international expansion underpin long-term growth. Dividend sustainability is challenged by an 89% payout ratio in FY26, but gradual EPS growth and minor dividend hikes should normalize payout to 60-65% over five years.
CLX Q3 Earnings Beat Estimates on Lower Spending, Cost Savings
Clorox tops Q3 EPS estimates on cost cuts despite flat sales. It trims the FY26 outlook after GOJO close and bigger margin pressure.
5 Quality Passive Income Blue-Chips That All Yield 5% and More Safely
Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable performance history.
Compared to Estimates, Clorox (CLX) Q3 Earnings: A Look at Key Metrics
The headline numbers for Clorox (CLX) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Clorox: Reduced Complexity Paves The Way For Multiple Expansion
Clorox is attractively valued after underperformance, offering a 5% dividend yield and normalization post-cyber attack and ERP disruptions. The recent Purell (GOJO) acquisition is set to be accretive to EBITDA and EPS by FY27, supporting top-line growth above the company's long-term algorithm. CLX trades at 14.5x FY27 EPS, with double-digit earnings growth and room for multiple expansion relative to peers, setting up 20% upside potential.
Clorox to Report Q3 Earnings: Here's What You Should Know
CLX heads into Q3 earnings with rising costs, soft demand and margin pressure, even as its IGNITE strategy and cost savings initiatives aim to stabilize performance.
Clorox (CLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JPMorgan Cuts Clorox to Underweight: A Stretched Consumer, Private Label Pressure and Cost Headwinds Make for a Toxic Mix
Clorox (NYSE:CLX) stock just picked up one of Wall Street's most bearish signals.
We Highlighted 3 Undervalued Dividend Aristocrats a Year Ago: Here's How They Did and 3 New Picks
A year ago, we identified three Dividend Aristocrats trading at compelling discounts to fair value.
Clorox: A Clean Portfolio Holding Through Market Volatility
The Clorox Company is seeing lower profits and sales volumes, but I see these as transitory setbacks. Shares in the cleaning products maker are trading near their 52-week lows, and I believe this presents an attractive opportunity for upside. The stock comes attached with what I view as an attractive dividend yield.
Clorox Leverages Digital and Operational Optimization to Aid Growth
CLX drives growth with innovation and digital upgrades, positioning its international expansion as a key long-term lever.
Can Clorox's Digital Push Accelerate Operational Efficiency?
CLX navigates ERP disruption and macro headwinds while advancing digital transformation to drive efficiency and margin gains.
